Evolent Health (EVH) Revenue & Revenue Breakdown
Evolent Health Revenue Highlights
Latest Revenue (Y)
$1.88B
Main Segment (Y)
Reportable Segment
Main Geography (Y)
Services Segment
Evolent Health Revenue by Period
Evolent Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $1.88B | -26.56% |
| 2024-12-31 | $2.55B | 30.09% |
| 2023-12-31 | $1.96B | 45.26% |
| 2022-12-31 | $1.35B | 48.91% |
| 2021-12-31 | $907.96M | -1.80% |
| 2020-12-31 | $924.64M | 34.57% |
| 2019-12-31 | $687.12M | 9.58% |
| 2018-12-31 | $627.06M | 44.17% |
| 2017-12-31 | $434.95M | 71.11% |
| 2016-12-31 | $254.19M | 162.38% |
| 2015-12-31 | $96.88M | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $25.67M | 207.58% |
| 2012-12-31 | $8.35M | - |
Evolent Health generated $1.88B in revenue during NA 2025, up -26.56% compared to the previous quarter, and up 202.91% compared to the same period a year ago.
Evolent Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | -100.00% |
| 2025-06-30 | $444.33M | -8.13% |
| 2025-03-31 | $483.65M | -25.19% |
| 2024-12-31 | $646.54M | 4.05% |
| 2024-09-30 | $621.40M | -3.98% |
| 2024-06-30 | $647.14M | 1.17% |
| 2024-03-31 | $639.65M | 15.03% |
| 2023-12-31 | $556.05M | 8.81% |
| 2023-09-30 | $511.01M | 8.93% |
| 2023-06-30 | $469.14M | 9.69% |
| 2023-03-31 | $427.69M | 11.83% |
| 2022-12-31 | $382.43M | 8.47% |
| 2022-09-30 | $352.58M | 10.20% |
| 2022-06-30 | $319.94M | 7.70% |
| 2022-03-31 | $297.06M | 19.61% |
| 2021-12-31 | $248.36M | 11.64% |
| 2021-09-30 | $222.47M | 0.19% |
| 2021-06-30 | $222.06M | 3.25% |
| 2021-03-31 | $215.07M | -20.91% |
| 2020-12-31 | $271.92M | 13.50% |
| 2020-09-30 | $239.57M | 10.25% |
| 2020-06-30 | $217.30M | -1.78% |
| 2020-03-31 | $221.23M | -6.47% |
| 2019-12-31 | $236.53M | 7.44% |
| 2019-09-30 | $220.14M | 14.68% |
| 2019-06-30 | $191.96M | -2.93% |
| 2019-03-31 | $197.76M | 2.41% |
| 2018-12-31 | $193.10M | 28.78% |
| 2018-09-30 | $149.95M | 3.91% |
| 2018-06-30 | $144.30M | 3.28% |
| 2018-03-31 | $139.71M | 22.85% |
| 2017-12-31 | $113.73M | 5.39% |
| 2017-09-30 | $107.91M | 0.79% |
| 2017-06-30 | $107.07M | 0.78% |
| 2017-03-31 | $106.24M | 20.71% |
| 2016-12-31 | $88.01M | 46.17% |
| 2016-09-30 | $60.21M | 6.53% |
| 2016-06-30 | $56.52M | 14.30% |
| 2016-03-31 | $49.45M | 7.36% |
| 2015-12-31 | $46.06M | 13.99% |
| 2015-09-30 | $40.41M | 288.00% |
| 2015-06-30 | $10.41M | -71.89% |
| 2015-03-31 | $37.04M | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | -100.00% |
| 2014-03-31 | $20.08M | - |
Evolent Health generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Evolent Health Revenue Breakdown
Evolent Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Reportable Segment | $1.88B | - | - | - | - |
| Evolent Health Services Segment | - | $2.55B | $1.96B | $407.50M | - |
| Clinical Solutions Segment | - | - | - | $944.51M | - |
| Transformation Services | - | - | - | - | $11.20M |
| Platforms And Operations Services | - | - | - | - | $896.75M |
Evolent Health's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $468.72M | $479.53M | $444.33M | $483.65M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Evolent Health Services Segment | - | - | - | - | $1.29B | $621.40M | $639.65M | $556.05M | $511.01M | $469.14M | $427.69M | $100.98M | $107.33M | $92.34M | $106.86M | - | - | - | - | - |
| Clinical Solutions Segment | - | - | - | - | - | - | - | - | - | - | - | $281.45M | $245.26M | $227.60M | $190.20M | - | - | - | - | - |
| Platforms And Operations Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $242.14M | $220.40M | $219.49M | $214.73M | $-4.86M |
| Transformation Services | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $6.22M | $2.08M | $2.56M | $345.00K | - |
| Service | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $241.68M |
| Premiums Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $30.24M |
Evolent Health's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).
Evolent Health Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|
| Services Segment | $690.39M | $458.99M | $32.92M |
Evolent Health's latest annual revenue breakdown by geography, as of Dec 20: Services Segment (100.00%).
Quarterly Revenue by Country
| Country | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services Segment | $187.73M | $181.08M | $161.77M | $159.84M | $4.72M | $171.00M | $143.63M | $147.29M | $157.06M | $116.23M | $110.84M | $10.16M |
Evolent Health's latest quarterly revenue breakdown by geography, as of Dec 20: Services Segment (100.00%).
Evolent Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMN | AMN Healthcare Services | $2.73B | $634.50M |
| EVH | Evolent Health | $1.88B | - |
| NUTX | Nutex Health | $875.26M | $267.80M |
| MYGN | Myriad Genetics | $824.50M | $213.10M |
| HSTM | HealthStream | $304.06M | $76.47M |
| BFLY | Butterfly Network | $97.61M | $21.49M |
| KURA | Kura Oncology | $67.48M | $20.75M |
| MGTX | MeiraGTx | $33.28M | $3.69M |
| PSNL | Personalis | - | - |
| REPL | Replimune Group | - | - |
| AVBP | ArriVent BioPharma | - | - |